Selagine

2315 W Taylor St Ste A
Chicago, IL 60612

SELAGINE Inc. is a spin-out company from the University of Illinois at Chicago (UIC) dedicated to developing innovative therapeutics for patients suffering from ocular surface diseases. These conditions arise from inflammatory, immunological, and infectious causes, highlighting the company's commitment to addressing critical health challenges in eye care.

Based in Chicago, SELAGINE Inc. leverages cutting-edge research and expertise from UIC to create novel solutions aimed at improving the quality of life for individuals affected by these debilitating conditions. The company's focus on ocular health positions it as a key player in the advancement of therapeutic options in the field.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.